3 ms·
what exactly is the mechanism of bioaccumulation in cancer cells specifically? Or is this merely an imaging method that will have to be conjugated to, say a ca
by dnautics 12y ago
what exactly is the mechanism of bioaccumulation in cancer cells specifically? Or is this merely an imaging method that will have to be conjugated to, say a cancer-marker antibody?
- Bikanta 12y agoyou are correct, this is primarily targeted to disease states with ligands such as antibodies, aptamers, fab fragments, etc.
- untilHellbanned 12y agoThis is the key issue. Detection by antibodies or some other label will be the true discovery. Binding that to nanodiamonds or whatever isn't the bottleneck.
- dnautics 12y agoWell we have plenty of biomarker candidates (aka human genome project) and, following them will come plenty of monoclonals, which should be relatively easy to humanize. The bottleneck may be 'bioinformatics', and I don't think bioinformatics is going to be a 'embarassingly parallelizable' problem, certainly not in the sense of "throw more people, computers, and bioinformaticians at the problem" sense.
- cowsandmilk 12y agoLooking at some details on the technology, I would have to disagree. Nanodiamonds seem to be a much better fluorescent label than what is traditionally conjugated to antibodies. Traditional conjugated fluorophores have high susceptibility to bleaching, so you have to sort them out from natural signals. With nanodiamonds, it appears you can bleach all the natural signals and get a clear signal from the nanodiamond. This is pretty cool.
- untilHellbanned 12y agoYou missed the point. Detecting the protein or whatever that is deregulated in disease early is the hard part, not the fluorophore or nanoparticle to which it conjugates.